6620.TWO
Price:
$95.5
Market Cap:
$15.03B
Handa Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China. The company provides Quetiapine XR for the treatment of Schizophrenia; and Dexlansoprazole DR capsules. It also develops ONCORE, a proprietary drug delivery technology that was developed to improve the patient compliance and safety of the tyrosine kinase inhibitor of oncology drugs; 505(b)(2)NDA, a therapeutic product; Tascenso ODT for the treatment of multiple sclerosis; and HND-033 and HND-027, an oncology products. In addition, the company develops HND-004, a diabetic drug; HND-032 for smoking cessation; and HND-026, a GI drug. Handa Pha...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2016-12-30
Stock Exchange
TWO
Ticker
6620.TWO
According to Handa Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 14.16B. This represents a change of 7.65% compared to the average of 13.16B of the last 4 quarters.
The mean historical Enterprise Value of Handa Pharmaceuticals, Inc. over the last ten years is 10.43B. The current 14.16B Enterprise Value has changed 13.49% with respect to the historical average. Over the past ten years (40 quarters), 6620.TWO's Enterprise Value was at its highest in in the March 2023 quarter at 24.83B. The Enterprise Value was at its lowest in in the September 2024 quarter at 8.98B.
Average
10.43B
Median
8.89B
Minimum
2.55B
Maximum
23.99B
Discovering the peaks and valleys of Handa Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 206.91%
Maximum Annual Enterprise Value = 23.99B
Minimum Annual Increase = -58.46%
Minimum Annual Enterprise Value = 2.55B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 9.96B | -58.46% |
| 2023 | 23.99B | 60.68% |
| 2022 | 14.93B | 90.89% |
| 2021 | 7.82B | 206.91% |
| 2020 | 2.55B | -22.65% |
The current Enterprise Value of Handa Pharmaceuticals, Inc. (6620.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
16.30B
5-year avg
11.85B
10-year avg
10.43B
Handa Pharmaceuticals, Inc.’s Enterprise Value is less than Grape King Bio Ltd (15.82B), less than TTY Biopharm Company Limited (20.51B), less than Synmosa Biopharma Corporation (17.65B), less than Alar Pharmaceuticals Inc. (16.50B), less than YungShin Global Holding Corporation (15.18B), greater than ScinoPharm Taiwan, Ltd. (11.80B), less than Sunmax Biotechnology Co., Ltd. (20.88B), less than Great Tree Pharmacy Co., Ltd. (19.48B), less than TaiMed Biologics Inc. (16.98B), less than EirGenix Inc. (17.64B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 15.82B | $18.74B | |
| 20.51B | $20.84B | |
| 17.65B | $15.94B | |
| 16.50B | $18.34B | |
| 15.18B | $15.24B | |
| 11.80B | $13.88B | |
| 20.88B | $21.30B | |
| 19.48B | $14.23B | |
| 16.98B | $17.32B | |
| 17.64B | $19.12B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Handa Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Handa Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Handa Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Handa Pharmaceuticals, Inc. (6620.TWO)?
What is the 3-year average Enterprise Value for Handa Pharmaceuticals, Inc. (6620.TWO)?
What is the 5-year average Enterprise Value for Handa Pharmaceuticals, Inc. (6620.TWO)?
How does the current Enterprise Value for Handa Pharmaceuticals, Inc. (6620.TWO) compare to its historical average?